Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics Statistics

Total Valuation

TCRT has a market cap or net worth of $5.24 million. The enterprise value is $4.83 million.

Market Cap	5.24M
Enterprise Value	4.83M

Important Dates

The next estimated earnings date is Monday, August 18, 2025, after market close.

Earnings Date	Aug 18, 2025
Ex-Dividend Date	n/a

Share Statistics

TCRT has 1.98 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	1.98M
Shares Outstanding	1.98M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.69%
Owned by Institutions (%)	13.06%
Float	1.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	467.75
Forward PS	n/a
PB Ratio	4.30
P/TBV Ratio	4.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	438.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.00

Current Ratio	1.00
Quick Ratio	0.30
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -139.03% and return on invested capital (ROIC) is -88.86%.

Return on Equity (ROE)	-139.03%
Return on Assets (ROA)	-63.78%
Return on Invested Capital (ROIC)	-88.86%
Return on Capital Employed (ROCE)	-393.38%
Revenue Per Employee	$11,000
Profits Per Employee	-$4.07M
Employee Count	1
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.43% in the last 52 weeks. The beta is -0.81, so TCRT's price volatility has been lower than the market average.

Beta (5Y)	-0.81
52-Week Price Change	+8.43%
50-Day Moving Average	3.57
200-Day Moving Average	2.46
Relative Strength Index (RSI)	34.79
Average Volume (20 Days)	64,286

Short Selling Information

The latest short interest is 56,663, so 2.86% of the outstanding shares have been sold short.

Short Interest	56,663
Short Previous Month	85,980
Short % of Shares Out	2.86%
Short % of Float	3.01%
Short Ratio (days to cover)	0.79

Income Statement

In the last 12 months, TCRT had revenue of $11,000 and -$4.07 million in losses. Loss per share was -$2.54.

Revenue	11,000
Gross Profit	-572,000
Operating Income	-4.16M
Pretax Income	-26.77M
Net Income	-4.07M
EBITDA	-4.16M
EBIT	-4.16M
Loss Per Share	-$2.54

Balance Sheet

The company has $319,000 in cash and n/a in debt, giving a net cash position of $319,000 or $0.16 per share.

Cash & Cash Equivalents	319,000
Total Debt	n/a
Net Cash	319,000
Net Cash Per Share	$0.16
Equity (Book Value)	1.06M
Book Value Per Share	0.66
Working Capital	5,000

Cash Flow

Operating Cash Flow	-3.83M
Capital Expenditures	n/a
Free Cash Flow	-3.83M
FCF Per Share	-$1.93

Margins

Gross Margin	n/a
Operating Margin	-37,836.36%
Pretax Margin	-37,000.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TCRT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	-0.05%
Earnings Yield	-79.10%
FCF Yield	-74.36%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 18, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Jul 18, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

TCRT has an Altman Z-Score of -610.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-610.62
Piotroski F-Score	2